[Federal Register Volume 76, Number 166 (Friday, August 26, 2011)]
[Notices]
[Pages 53477-53478]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2011-21708]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Medicare & Medicaid Services
[CMS-3251-N2]
Medicare Program; Meeting of the Medicare Evidence Development
and Coverage Advisory Committee; Cancellation of the September 21, 2011
Meeting
AGENCY: Centers for Medicare & Medicaid Services (CMS), HHS.
ACTION: Notice of meeting.
-----------------------------------------------------------------------
SUMMARY: This notice announces the cancellation of the September 21,
2011 public meeting of the Medicare Evidence Development & Coverage
Advisory Committee (MEDCAC) (``Committee'') that was published in the
July 22, 2011 Federal Register (76 FR 44011 through 44012). This notice
also announces a public meeting on Wednesday, March 21, 2012. The
Committee generally provides advice and recommendations concerning the
adequacy of scientific evidence needed to determine whether certain
medical items and services can be covered under the Medicare statute.
This meeting will focus on the currently available evidence regarding
antivascular endothelial growth factor (anti-VEGF) treatment of
diabetic macular edema (DME). This meeting is open to the public in
accordance with the Federal Advisory Committee Act (5 U.S.C. App. 2,
section 10(a)).
DATES: Meeting Date: The public meeting will be held on Wednesday,
March 21, 2012 from 7:30 a.m. until 4:30 p.m., Daylight Saving Time
(DST).
Deadline for Submission of Written Comments: Written comments must
be received at the address specified in the ADDRESSES section of this
notice by 5 p.m. Eastern Standard Time (EST), Tuesday, February 21,
2012. Once submitted, all comments are final.
Deadlines for Speaker Registration and Presentation Materials: The
deadline to register to be a speaker and to submit PowerPoint
presentation materials and writings that will be used in support of an
oral presentation, is 5 p.m., EST on Tuesday, February 21, 2012.
Speakers may register by phone or via e-mail by contacting the person
listed in the FOR FURTHER INFORMATION CONTACT section of this notice.
Presentation materials must be received at the address specified in the
ADDRESSES section of this notice.
Deadline for All Other Attendees Registration: Individuals may
register online at http://www.cms.gov/apps/events/upcomingevents.asp?strOrderBy=1&type=3 or by phone by contacting the
person listed in the FOR FURTHER INFORMATION CONTACT section of this
notice by 5 p.m. DST, Friday, March 16, 2012.
We will be broadcasting the meeting live via Webcast at http://www.cms.gov/live/.
Deadline for Submitting a Request for Special Accommodations:
Persons attending the meeting who are hearing or visually impaired, or
have a condition that requires special assistance or accommodations,
are asked to contact the Executive Secretary as specified in the FOR
FURTHER INFORMATION CONTACT section of this notice no later than 5
p.m., EST Friday, March 2, 2012.
ADDRESSES: Meeting Location: The meeting will be held in the main
auditorium of the Centers for Medicare & Medicaid Services, 7500
Security Boulevard, Baltimore, MD 21244.
Submission of Presentations and Comments: Presentation materials
and written comments that will be presented at the meeting must be
submitted via e-mail to [email protected] or by regular
mail to the contact listed in the FOR FURTHER INFORMATION CONTACT
section of this notice by the date specified in the DATES section of
this notice.
FOR FURTHER INFORMATION CONTACT: Maria Ellis, Executive Secretary for
MEDCAC, Centers for Medicare & Medicaid Services, Office of Clinical
Standards and Quality, Coverage and Analysis Group, S3-02-01, 7500
Security Boulevard, Baltimore, MD 21244 or contact Ms. Ellis by phone
(410-786-0309) or via e-mail at [email protected].
SUPPLEMENTARY INFORMATION:
I. Background
MEDCAC, formerly known as the Medicare Coverage Advisory Committee
(MCAC), provides advice and recommendations to CMS regarding clinical
issues. (For more information on MCAC, see the December 14, 1998
Federal Register (63 FR 68780).) This notice announces the March 21,
2012, public meeting of the Committee. During this meeting, the
Committee will discuss the currently available evidence regarding
antivascular endothelial growth factor (anti-VEGF) treatment of
diabetic macular edema (DME). Background information about this topic,
including panel materials, is available at http://www.cms.gov/medicare-coverage-database/indexes/medcac-meetings-index.aspx?bc=BAAAAAAAAAAA&.
CMS will no longer be providing paper copies of the handouts for the
meeting. Electronic copies of all the meeting materials will be on the
CMS Web site no later than 2 business days before the meeting. We
encourage the participation of appropriate organizations with expertise
in the treatment of diabetic retinopathy (DR) and DME.
II. Meeting Format
This meeting is open to the public. The agenda for the day of the
meeting offers two opportunities for the public to participate as
either a registered scheduled speaker or an unscheduled speaker. The
Committee will hear oral presentations from the registered scheduled
speakers for approximately 45 minutes. Time allotted for each
presentation may be limited. If the number of registrants requesting to
speak is greater than can be reasonably accommodated during the
scheduled open public hearing session, CMS may conduct a lottery to
determine the speakers for the scheduled open public hearing session.
The contact person will notify interested persons regarding their
request to speak by February 23, 2012. Your comments should focus on
issues specific to the list of topics that we have proposed to the
Committee. The list of research topics to be discussed at the meeting
will be available on the following Web site prior to the meeting:
http://www.cms.gov/medicare-coverage-database/indexes/medcac-meetings-index.aspx?bc=BAAAAAAAAAAA&. We require that you declare at the
[[Page 53478]]
meeting whether you have any financial involvement with manufacturers
(or their competitors) of any items or services being discussed.
The Committee will deliberate openly on the topics under
consideration. Interested persons may observe the deliberations, but
the Committee will not hear further comments during this time except at
the request of the chairperson. The Committee will also allow a 15-
minute open public session for any unscheduled speaker to address
issues specific to the topics under consideration. At the conclusion of
the day, the members will vote and the Committee will make its
recommendation(s) to CMS.
III. Registration Instructions
CMS' Coverage and Analysis Group is coordinating meeting
registration. While there is no registration fee, individuals must
register to attend. You may register online at http://www.cms.gov/apps/events/upcomingevents.asp?strOrderBy=1&type=3 or by phone by contacting
the person listed in the FOR FURTHER INFORMATION CONTACT section of
this notice by the deadline listed in the DATES section of this notice.
Please provide your full name (as it appears on your state-issued
driver's license), address, organization, telephone, fax number(s), and
e-mail address. You will receive a registration confirmation with
instructions for your arrival at the CMS complex or you will be
notified the seating capacity has been reached.
IV. Security, Building, and Parking Guidelines
This meeting will be held in a Federal government building;
therefore, Federal security measures are applicable. We recommend that
confirmed registrants arrive reasonably early, but no earlier than 45
minutes prior to the start of the meeting, to allow additional time to
clear security. Security measures include the following:
Presentation of government-issued photographic
identification to the Federal Protective Service or Guard Service
personnel.
Inspection of vehicle's interior and exterior (this
includes engine and trunk inspection) at the entrance to the grounds.
Parking permits and instructions will be issued after the vehicle
inspection.
Inspection, via metal detector or other applicable means
of all persons brought entering the building. We note that all items
brought into CMS, whether personal or for the purpose of presentation
or to support a presentation, are subject to inspection. We cannot
assume responsibility for coordinating the receipt, transfer,
transport, storage, set-up, safety, or timely arrival of any personal
belongings or items used for presentation or to support a presentation.
Note: Individuals who are not registered in advance will not be
permitted to enter the building and will be unable to attend the
meeting. The public may not enter the building earlier than 45
minutes prior to the convening of the meeting. All visitors must be
escorted in areas other than the lower and first floor levels in the
Central Building.
Authority: 5 U.S.C. App. 2, section 10(a).
(Catalog of Federal Domestic Assistance Program No. 93.773,
Medicare--Hospital Insurance; and Program No. 93.774, Medicare--
Supplementary Medical Insurance Program)
Dated: August 17, 2011.
Patrick Conway,
CMS Chief Medical Officer and Director, Office of Clinical Standards
and Quality Centers for Medicare & Medicaid Services.
[FR Doc. 2011-21708 Filed 8-25-11; 8:45 am]
BILLING CODE 4120-01-P